FindTrial
Sign In

Early Phase 2 Clinical Study of JTS-661 - Efficacy and Safety Study -

Early Phase 2 Clinical Study of JTS-661 - Efficacy and Safety Study -

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080223725
Enrollment
240
Registered
2017-11-21
Start date
2017-11-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pruritus

Interventions

investigational material(s) Generic name etc : JTS-661 INN of investigational material : Serlopitant Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for Investigati

Sponsors

JAPAN TABACCO INC.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Inadequate response to current therapies - Numerical rating scale score of 6 or more

Exclusion criteria

Exclusion criteria:

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026